Limbach Holdings (LMB) Reports Q3 Loss of $0.46, Revenues Miss; Offers FY18 Revenue Mid-Point Outlook Below Consensus
Go back to Limbach Holdings (LMB) Reports Q3 Loss of $0.46, Revenues Miss; Offers FY18 Revenue Mid-Point Outlook Below Consensus| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 51.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.74 | 52 Week High | $0.15 | |||
| Open | $51.74 | 52 Week Low | $0.15 | |||
| Day High | $51.74 | P/E | N/A | |||
| Day Low | $51.74 | EPS | $0.00 | |||
| Volume | 138 | |||||
